Description: Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
Home Page: www.neclife.com
SCO 38-39
Chandigarh,
160009
India
Phone:
91 17 2504 7915
Officers
| Name | Title |
|---|---|
| Mr. Sanjiv Goyal | Chairman & MD |
| Mr. Puneet Sud B.Tech. | Director of Operations & Wholetime Director |
| Mr. Amit Chadah | Chief Executive Officer |
| Mr. Sushil Kapoor | Chief Financial Officer |
| Ms. Neha Vaishnav | Company Secretary & Compliance Officer |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 74.4255 |
| Price-to-Book MRQ: | 0.6912 |
| Price-to-Sales TTM: | 0.4517 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 1686 |